PRESS RELEASE
27 January 2021

Cell & Gene Therapy: Understanding & Overcoming Challenges In Pricing & Patient Access

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
Linda Pissott Reig shareholder and co-chair of the firm's FDA practice, will be serving as a moderator for an upcoming webinar...
United States

Feb 17 2021
9:00 AM - 10:45 AM

Linda Pissott Reig shareholder and co-chair of the firm's FDA practice, will be serving as a moderator for an upcoming webinar, "Cell & Gene Therapy: Understanding & Overcoming Challenges in Pricing & Patient Access" hosted by BioNJ. The esteemed panel will discuss the trajectory of cell and gene therapies in the U.S. market.

Register for the webinar here.

PRESS RELEASE
27 January 2021

Cell & Gene Therapy: Understanding & Overcoming Challenges In Pricing & Patient Access

United States

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More